⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BIAF News
bioAffinity Technologies, Inc. Common Stock
Form 8-K
sec.gov
BIAFW
BIAF
bioAffinity Technologies Announces Validation Study with Brooke Army Medical Center to Expand Sample Collection Options for the CyPath® Lung Noninvasive Early Detection Lung Cancer Test
businesswire.com
BIAF
Form 8-K
sec.gov
BIAFW
BIAF
New Case Study Highlights Ability of bioAffinity Technologies’ CyPath® Lung to Reduce Diagnostic Burden for Patients At Risk for Lung Cancer
businesswire.com
BIAF
Clinical Utility of bioAffinity Technologies’ CyPath® Lung Test Demonstrated in Real-World Case Study
businesswire.com
BIAF
bioAffinity Technologies Appoints Nationally Recognized Pulmonary and Lung Cancer Authorities to its Medical and Scientific Advisory Board
businesswire.com
BIAFW
BIAF
bioAffinity Technologies Reports Third Quarter 2025 Financial Results
businesswire.com
BIAF